J Pediatr Infect Dis 2010; 05(01): 107-110
DOI: 10.3233/JPI-2010-0211
Georg Thieme Verlag KG Stuttgart – New York

Thymus inflammatory myofibroblastic tumor in child with an Interleukin-12-receptor beta 1 deficiency (IL12rβ1)

Liliana Bezrodnik
a   Servicios de Inmunología, Hospital de Niños "Dr. R. Gutiérrez", Buenos Aires, Argentina
,
Daniela Di Giovanni
a   Servicios de Inmunología, Hospital de Niños "Dr. R. Gutiérrez", Buenos Aires, Argentina
,
Elena De Matteo
b   Servicios de Anatomía Patológica, Hospital de Niños "Dr. R. Gutiérrez", Buenos Aires, Argentina
,
Silvana Maglio
b   Servicios de Anatomía Patológica, Hospital de Niños "Dr. R. Gutiérrez", Buenos Aires, Argentina
,
Cristina Cerqueiro
c   Servicios de Tisiología, Hospital de Niños "Dr. R. Gutiérrez", Buenos Aires, Argentina
› Author Affiliations

Subject Editor:
Further Information

Publication History

13 March 2009

05 April 2009

Publication Date:
28 July 2015 (online)

Abstract

Mendelian susceptibility to mycobacterial disease is a rare syndrome, which results in predisposition to clinical disease caused by poorly virulent mycobacterial species such as the bacille Calmette-Guérin vaccines and nontuberculous environmental mycobacteria. Such patients are also susceptible to virulent Mycobacterium tuberculosis but rarely present other unusual infectious diseases, with the exception of nontyphoid Salmonella, which can affect around half of them. We report a boy with a novel interleukin-12 receptor beta 1 deficiency, who developed BCG-osis and an inflammatory myofibroblastic tumor when he was 11 months. Clinically IL12 deficiency should be considered in genetic diagnosis of patients with an inherited IL12/INFγ axis and thymus affected. We do not know if the novel genetic diagnosis of our patient could be a factor of development of thymus lesion.